Arpin蛋白在前列腺癌中的表达及临床意义(4)
[12]Zhang C,Hai L,Zhu M,et al.Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells[J].Oncotarget,2017,8(20):33 353-33 364.
[13]Buck KB,Schaefer AW,Schoonderwoert VT,et al.Local ARP2/3-dependent actin assembly modulates applied traction force during apcam adhesion site maturation[J].Mol Biol Cell,2017,28(1):98-110.
[14]Bendell AC,Williamson EK,Chen CS,et al.The Arp2/3 complex binding protein HS1 is required for efficient dendritic cell random migration and force generation[J].Integr Biol (Camb),2017,9(8):695-708.
[15]Krause M,Gautreau A.Steering cell migration:lamellipodium dynamics and the regulation of directional persistence[J].Nat Rev Mol Cell Biol,2014,15(9):577-590.
[16]Prass M,Jacobson K,Mogilner A,et al.Direct measurement of the lamellipodial protrusive force in a migrating cell[J].J Cell Biol,2006,174(6):767-772.
[17]Fizazi K,Bosserman L,Gao G,et al.Denosumab treatment of prostate cancer with bone metastases and increased urine n-telopeptide levels after therapy with intravenous bisphosphonates:results of a randomized phase ii trial[J].J Urol,2013,189(1 Suppl):S51- S57; discussion S57- S58.
[18]Smith AD,Roda D,Yap TA.Strategies for modern biomarker and drug development in oncology[J].J Hematol Oncol,2014,7(7):70-71.
(收稿日期:2018-11-12 本文編辑:许俊琴), http://www.100md.com(韩东岳 赵海军 綦海燕)
[13]Buck KB,Schaefer AW,Schoonderwoert VT,et al.Local ARP2/3-dependent actin assembly modulates applied traction force during apcam adhesion site maturation[J].Mol Biol Cell,2017,28(1):98-110.
[14]Bendell AC,Williamson EK,Chen CS,et al.The Arp2/3 complex binding protein HS1 is required for efficient dendritic cell random migration and force generation[J].Integr Biol (Camb),2017,9(8):695-708.
[15]Krause M,Gautreau A.Steering cell migration:lamellipodium dynamics and the regulation of directional persistence[J].Nat Rev Mol Cell Biol,2014,15(9):577-590.
[16]Prass M,Jacobson K,Mogilner A,et al.Direct measurement of the lamellipodial protrusive force in a migrating cell[J].J Cell Biol,2006,174(6):767-772.
[17]Fizazi K,Bosserman L,Gao G,et al.Denosumab treatment of prostate cancer with bone metastases and increased urine n-telopeptide levels after therapy with intravenous bisphosphonates:results of a randomized phase ii trial[J].J Urol,2013,189(1 Suppl):S51- S57; discussion S57- S58.
[18]Smith AD,Roda D,Yap TA.Strategies for modern biomarker and drug development in oncology[J].J Hematol Oncol,2014,7(7):70-71.
(收稿日期:2018-11-12 本文編辑:许俊琴), http://www.100md.com(韩东岳 赵海军 綦海燕)